Systematische ÜbersichtMetaanalyse
Real-World Endoscopic Outcomes of Risankizumab in Crohn’s Disease: A Systematic Review and Meta-analysis
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S618
DOI: 10.1055/s-0046-1821818 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von A D Bota und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bota, A. D., Saftoiu, A., Arstiom, K., & Tieranu, C. G. (2026). Real-World Endoscopic Outcomes of Risankizumab in Crohn’s Disease: A Systematic Review and Meta-analysis. Endoscopy, 58(S 03 S 03), S618. https://doi.org/10.1055/s-0046-1821818
Vancouver
Bota AD, Saftoiu A, Arstiom K, Tieranu CG. Real-World Endoscopic Outcomes of Risankizumab in Crohn’s Disease: A Systematic Review and Meta-analysis. Endoscopy. 2026;58(S 03 S 03):S618. doi:10.1055/s-0046-1821818
BibTeX
@article{Bota2026,
author = {Bota, A D and Saftoiu, A and Arstiom, K and Tieranu, C G},
title = {Real-World Endoscopic Outcomes of Risankizumab in Crohn’s Disease: A Systematic Review and Meta-analysis},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S618},
doi = {10.1055/s-0046-1821818}
}
EUVIMED